Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis

Área de publicación Neurociencia Cognitiva
Tipo de publicación Articles
Lugar de publicación Frontiers in Aging Neuroscience
Fecha de publicación 2022
Autores Natalia Ogonowski - Claudia Duran-Aniotz - Stefanny Salcidua - Constanza Avalos - Paulina Orellana - León T, Chamorro-Veloso N, Valls C, Bisquertt A, Renteria M

This systematic review aims to describe the current status of Alzheimer’s Disease-related target genes modulated by miRNAs differentially expressed in peripheral fluid samples in MCI subjects to identify potential miRNA biomarkers in early stages of Alzheimer’s Disease. Serum, plasma and other body fluid miRNAs have emerged as a promising source of biomarkers for mild cognitive impairment and cognitive impairments related to Alzheimer’s disease.

Ver publicación
Social Media